|
WO2021053199A1
|
|
Single-domain antibodies directed against lilrb2
|
|
CA3110905A1
|
|
Chimeric antigen receptors against multiple hla-g isoforms
|
|
WO2020043903A1
|
|
Method to assess car functionality
|
|
WO2018206512A1
|
|
Recombinant measles vaccine expressing htert
|
|
MX2018014979A
|
|
Anti hla-g specific antibodies.
|
|
EP3359183A1
|
|
Polyepitope constructs for use in immunotherapy
|
|
WO2015063112A1
|
|
Gene electrotransfer into skin cells
|
|
CN106061509A
|
|
A telomerase encoding dna vaccine
|
|
EP3003359A1
|
|
Apobec3a as an anti-tumor agent
|
|
AU2014242915A1
|
|
A cancer vaccine for cats
|
|
AU2014242916A1
|
|
A cancer vaccine for dogs
|
|
US2016272724A1
|
|
Antibodies and fragments thereof raised against the alpha-3 domain of HLA-G protein, methods and means for their preparation, and uses thereof
|
|
EP2639299A1
|
|
Universal cancer peptides derived from telomerase
|
